Us Bancorp \De\ Rubius Therapeutics, Inc. Transaction History

Us Bancorp \De\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.79 - $5.98 $265 - $2,009	-336 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$4.25 - $10.4 $4,037 - $9,880	-950 Reduced 73.87%	336 $2,000
Q3 2021 Nov 10, 2021	SELL	$17.6 - $25.91 $774 - $1,140	-44 Reduced 3.31%	1,286 $23,000
Q2 2021 Aug 05, 2021	BUY	$22.26 - $28.43 $979 - $1,250	44 Added 3.42%	1,330 $32,000
Q4 2020 Feb 04, 2021	BUY	$4.23 - $8.73 $5,439 - $11,226	1,286 New	1,286 $10,000
Q3 2020 Nov 10, 2020	SELL	$4.65 - $6.25 $943 - $1,268	-203 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$4.01 - $6.88 $236 - $405	-59 Reduced 22.52%	203 $1,000
Q1 2020 May 13, 2020	BUY	$3.74 - $9.84 $979 - $2,578	262 New	262 $1,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.